BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 21309043)

  • 21. Correction of disease-associated exon skipping by synthetic exon-specific activators.
    Cartegni L; Krainer AR
    Nat Struct Biol; 2003 Feb; 10(2):120-5. PubMed ID: 12524529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of common single-nucleotide polymorphisms on exon 9 and exon 12 skipping in nonmutated CFTR alleles.
    Steiner B; Truninger K; Sanz J; Schaller A; Gallati S
    Hum Mutat; 2004 Aug; 24(2):120-9. PubMed ID: 15241793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disruption of the splicing enhancer sequence within exon 27 of the dystrophin gene by a nonsense mutation induces partial skipping of the exon and is responsible for Becker muscular dystrophy.
    Shiga N; Takeshima Y; Sakamoto H; Inoue K; Yokota Y; Yokoyama M; Matsuo M
    J Clin Invest; 1997 Nov; 100(9):2204-10. PubMed ID: 9410897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple sequence variants of BRCA2 exon 7 alter splicing regulation.
    Gaildrat P; Krieger S; Di Giacomo D; Abdat J; Révillion F; Caputo S; Vaur D; Jamard E; Bohers E; Ledemeney D; Peyrat JP; Houdayer C; Rouleau E; Lidereau R; Frébourg T; Hardouin A; Tosi M; Martins A
    J Med Genet; 2012 Oct; 49(10):609-17. PubMed ID: 22962691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exon inclusion is dependent on predictable exonic splicing enhancers.
    Zhang XH; Kangsamaksin T; Chao MS; Banerjee JK; Chasin LA
    Mol Cell Biol; 2005 Aug; 25(16):7323-32. PubMed ID: 16055740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ASA E382K disrupts a potential exonic splicing enhancer and causes exon skipping, but missense mutations in ASA are not associated with ESEs.
    Shotelersuk V; Desudchit T; Tongkobpetch S
    Int J Mol Med; 2004 Oct; 14(4):683-9. PubMed ID: 15375602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of germline mutations in the BRCA1 gene by RNA-based sequencing.
    Jakubowska A; Górski B; Byrski T; Huzarski T; Gronwald J; Menkiszak J; Cybulski C; Debniak T; Hadaczek P; Scott RJ; Lubinski J
    Hum Mutat; 2001 Aug; 18(2):149-56. PubMed ID: 11462239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of DAZAP1 and hnRNPA1/A2 to an exonic splicing silencer in a natural BRCA1 exon 18 mutant.
    Goina E; Skoko N; Pagani F
    Mol Cell Biol; 2008 Jun; 28(11):3850-60. PubMed ID: 18391021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intronic alterations in BRCA1 and BRCA2: effect on mRNA splicing fidelity and expression.
    Chen X; Truong TT; Weaver J; Bove BA; Cattie K; Armstrong BA; Daly MB; Godwin AK
    Hum Mutat; 2006 May; 27(5):427-35. PubMed ID: 16619214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-base substitution at the last nucleotide of exon 6 (c.671G>A), resulting in the skipping of exon 6, and exons 6 and 7 in human succinyl-CoA:3-ketoacid CoA transferase (SCOT) gene.
    Yamada K; Fukao T; Zhang G; Sakurai S; Ruiter JP; Wanders RJ; Kondo N
    Mol Genet Metab; 2007 Mar; 90(3):291-7. PubMed ID: 17169596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exon skipping through the creation of a putative exonic splicing silencer as a consequence of the cystic fibrosis mutation R553X.
    Aznarez I; Zielenski J; Rommens JM; Blencowe BJ; Tsui LC
    J Med Genet; 2007 May; 44(5):341-6. PubMed ID: 17475917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A high proportion of DNA variants of BRCA1 and BRCA2 is associated with aberrant splicing in breast/ovarian cancer patients.
    Sanz DJ; Acedo A; Infante M; Durán M; Pérez-Cabornero L; Esteban-Cardeñosa E; Lastra E; Pagani F; Miner C; Velasco EA
    Clin Cancer Res; 2010 Mar; 16(6):1957-67. PubMed ID: 20215541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Listening to silence and understanding nonsense: exonic mutations that affect splicing.
    Cartegni L; Chew SL; Krainer AR
    Nat Rev Genet; 2002 Apr; 3(4):285-98. PubMed ID: 11967553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ex vivo splicing assays of mutations at noncanonical positions of splice sites in USHER genes.
    Le Guédard-Méreuze S; Vaché C; Baux D; Faugère V; Larrieu L; Abadie C; Janecke A; Claustres M; Roux AF; Tuffery-Giraud S
    Hum Mutat; 2010 Mar; 31(3):347-55. PubMed ID: 20052763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SR proteins and hnRNP H regulate the splicing of the HIV-1 tev-specific exon 6D.
    Caputi M; Zahler AM
    EMBO J; 2002 Feb; 21(4):845-55. PubMed ID: 11847131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive prediction of mRNA splicing effects of BRCA1 and BRCA2 variants.
    Mucaki EJ; Ainsworth P; Rogan PK
    Hum Mutat; 2011 Jul; 32(7):735-42. PubMed ID: 21523855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two silent substitutions in the PDHA1 gene cause exon 5 skipping by disruption of a putative exonic splicing enhancer.
    Boichard A; Venet L; Naas T; Boutron A; Chevret L; de Baulny HO; De Lonlay P; Legrand A; Nordman P; Brivet M
    Mol Genet Metab; 2008 Mar; 93(3):323-30. PubMed ID: 18023225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three exonic mutations in polycystic kidney disease-2 gene (PKD2) alter splicing of its pre-mRNA in a minigene system.
    Gonzalez-Paredes FJ; Ramos-Trujillo E; Claverie-Martin F
    Gene; 2016 Mar; 578(1):117-23. PubMed ID: 26692149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel mutation (c.951C>T) in an exonic splicing enhancer results in exon 10 skipping in the human mitochondrial acetoacetyl-CoA thiolase gene.
    Fukao T; Horikawa R; Naiki Y; Tanaka T; Takayanagi M; Yamaguchi S; Kondo N
    Mol Genet Metab; 2010 Aug; 100(4):339-44. PubMed ID: 20488739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18.
    Fraile-Bethencourt E; Díez-Gómez B; Velásquez-Zapata V; Acedo A; Sanz DJ; Velasco EA
    PLoS Genet; 2017 Mar; 13(3):e1006691. PubMed ID: 28339459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.